Now a new study from Boston University School of Medicine (BUSM) highlights the impact that structural racism and residential segregation has on NSCLC outcomes.

Getty Images


June 29, 2021 — Lung cancer remains the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for 80-85 percent cases of lung cancer and when diagnosed early, has a five-year survival rate of 50-80 percent. Black patients have lower overall incidence of NSCLC than white patients, but are more likely to be diagnosed at later stages. They also are less likely to receive surgery for early-stage cancer.

Now a new study from Boston University School of Medicine (BUSM) highlights the impact that structural racism and residential segregation has on NSCLC outcomes.

The researchers analyzed patient data from the Surveillance, Epidemiology and End Results Program—a database of Black and white patients diagnosed with NSCLC from 2004-2016 in the 100 most populous counties. They found that Black lung cancer patients living in the most segregated U.S. counties were 49 percent more likely to be diagnosed at an advanced stage, compared to those living in the least segregated counties. Among those with early-stage lung cancer, Black patients in highly segregated areas were 47 percent less likely to receive surgery. Segregation was used in this study as a proxy for historic housing discrimination and the enduring structural racism that has resulted from it.

"Our study suggests that Black patients have a greater likelihood of presenting at advanced stage than their white counterparts, a disparity that disappears at low levels of segregation. Similarly, higher residential segregation is associated with increased risk of advanced stage for Black patients but not white. This may be due to factors such as lack of access to routine medical care and lack of routine screenings for Black patients in segregated areas," explained corresponding author Kei Suzuki, MD, assistant professor of surgery at BUSM.

According to the researchers, fewer Black patients are considered eligible for lung cancer screening criteria and also are less likely to complete screening. For many diseases including lung cancer, Black patients of lower socioeconomic status tend to present to their physician only when symptomatic, aligning with a later stage of disease.

"Broadly, urban policy can serve to address the structural factors leading to these outcomes. Most immediately, clinicians and healthcare institutions can focus screening efforts in these minoritized communities and realize the racialized socioeconomic implications that may impact access to care, which may delay definitive care," added Suzuki, who also is a thoracic surgeon at Boston Medical Center.

These findings appear online in the journal Annals of Thoracic Surgery and was presented virtually as an oral presentation at the Society of Thoracic Surgery 2021 Annual Meeting on Jan. 31, 2021.

For more information: www.bmc.org

Related Lung Imaging Content:

ACR Urges Radiologists to Provide Input to CMS Lung Cancer Screening Coverage Analysis

Calculator That Predicts Risk of Lung Cancer Underperforms in Diverse Populations

Sculpting Radiation Beam Spares Lung Cancer Patients from Severe, Disabling Complication

Lung Cancer Screening Predicts Risk of Death from Heart Disease

Risk Prediction to Reduce Minority Disparities in USPSTF Lung Cancer Screening Guidelines

Related Content

News | Ultrasound Women's Health

October 14, 2021 — In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto ...

Time October 14, 2021
arrow
News | Lung Imaging

October 11, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), percutaneous image-guided microwave and ...

Time October 11, 2021
arrow
News | Women's Health

October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S ...

Time October 08, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
News | Radiation Therapy

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
News | Women's Health

October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients ...

Time October 05, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Artificial Intelligence

September 24, 2021 — Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to ...

Time September 24, 2021
arrow
Subscribe Now